openPR Logo
Press release

Chikungunya Treatment Market Outlook 2020: Opportunity and Growth Analysis - Dominated By Themis Bioscience GmbH, Arno Therapeutics, Inc, Bharat Biotech

03-17-2020 10:23 AM CET | Health & Medicine

Press release from: Data Bridge Market Research

Global chikungunya treatment market

Global chikungunya treatment market

Global chikungunya treatment market is growing at a substantial CAGR in the forecast period of 2019-2026. The report contains data of the base year 2018 and historic year 2017. This rise in market value can be attributed to the increasing prevalence of dengue in tropical and sub-tropical regions, increased government funding to fight against dengue, unmet market needs of managing dengue burden around the world and rise in investment from government, public & private organizations for the development of novel drugs. The key market players in the global chikungunya treatment market are Themis Bioscience GmbH, Arno Therapeutics, Inc, Bharat Biotech, Paradigm Biopharmaceuticals Ltd, Nano Therapeutics Pvt Ltd, Hawaii Biotech Inc, Indian Immunologicals Limited, Inovio Pharmaceuticals, Inc., Integral Molecular, Integrated BioTherapeutics, Inc, Mapp Biopharmaceautical, Moderna, Inc., MYMETICS, Zydus Cadila, Takeda Pharmaceutical Company Limited and others

Get Sample Report + All Related Graphs & Charts @
https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-chikungunya-treatment-market

Competitive Analysis:

Global chikungunya treatment market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of chikungunya treatment market for Global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Market Definition: Global Chikungunya Treatment Market


Chikungunya virus infection is also known as chikungunya fever is characterized by mosquito-borne viral disease which is spread by a bite of an infected Aedes species mosquito including aedes aegypti and aedes albopictus. The most common symptoms of infection are fever and joint pain.

According to statistics published in the WHO, it was estimated a total of 349,936 suspected and 146,914 laboratory confirmed cases of chikungunya has been reported to the PAHO regional office. Of these, 265, 000 suspected cases were locally reported from the Brazil. The market growth is increased by introduction of novel therapies and rise in government initiatives may increase the chikungunya virus infection drug market.

Market Drivers

Increasing prevalence of chikungunya in tropical and sub-tropical regions is driving the market growth.
Increased government funding to fight against chikungunya is accelerating the market growth
Promising chikungunya pipeline is expected to drive the market growth


Demand of novel therapies for treating chikungunya virus infections is also acting as a driver for the market
Market Restraints

Lack or insufficient healthcare infrastructure in underdeveloped and developing regions is hampering the market growth
Lack of awareness related to symptoms of chikungunya is hindering the market growth
High cost of the treatment is restraining the market growth.
Segmentation: Global Chikungunya Treatment Market

By Strain Type

Aedes Aegypti
Aedes Albopictus
By Treatment

Medication
Vaccination
By Drug Class

Analgesics
Antipyretics
Vaccines
Others
By Drugs

Acetaminophen
Dengvaxia
Others
By Route of Administration

Oral
Parenteral
By Distribution Channel

Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
By End-Users

Hospitals
Homecare
Specialty Clinics
Grab Your Report at an Impressive 30% Discount! Please click Here @
https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-chikungunya-treatment-market

Key Developments in the Market

In February 2019, Moderna, Inc, has initiated first dose in patients in a phase I clinical trial for mRNA-1944, an anti-Chikungunya antibody for the treatment of chikungunya virus infections. The dosing of first monoclonal antibody encoded by mRNA in human subject is a significant milestone for a company and represents advances in the novel treatment through targeted mode of action.
In February 2019, Themis Bioscience GmbH received the fast track designation from the FDA for MV-CHIK, a vaccine for the treatment of chikungunya viral infections. The Fast Track designation for MV-CHIK accelerates the review timeline and enhances the attraction with the FDA so that lead candidate can reach the market expeditiously.

In September 2016, Takeda Pharmaceutical Company Limited entered into research collaboration with Zydus Cadila to develop a novel vaccine for the treatment of chikungunya virus infection. This collaboration will address the urgent and neglected unmet medical need as well as expedite the access to novel treatment options for patients suffering from chikungunya.

Reasons to Purchase this Report:

Current and future of global chikungunya treatment market outlook in the developed and emerging markets.
The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period.
Regions/Countries that are expected to witness the fastest growth rates during the forecast period.
The latest developments, market shares, and strategies that are employed by the major market players.

Note: If you have any special requirements, please let us know and we will offer you the report as you want.

Contact:

Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475

Email: Corporatesales@databridgemarketresearch.com

About Data Bridge Market Research:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Chikungunya Treatment Market Outlook 2020: Opportunity and Growth Analysis - Dominated By Themis Bioscience GmbH, Arno Therapeutics, Inc, Bharat Biotech here

News-ID: 1970602 • Views:

More Releases from Data Bridge Market Research

Aquaculture Products Market Size, Share, Trends, Key Drivers, Growth Opportuniti …
Aquaculture Products Market business report provides a profound overview of product specification, technology, product type and production analysis considering major factors such as revenue, cost, and gross margin. The data and information collected to generate this top-notch market report has been derived from the trusted sources such as company websites, white papers, journals, and mergers etc. Aquaculture Products Market report includes basic, secondary and advanced information related to the global
Hydrochloric Acid Market Size, Share, Trends, Demand, Future Growth, Challenges …
Data Bridge Market research has recently released expansive research titled Global Hydrochloric Acid Market  guarantees you will remain better informed than your competition.The report is formulated based on the market type, organization size, availability on-premises, the end-users' organization type, and the availability in areas such as North America, South America, Europe, Asia-Pacific and Middle East & Africa. Businesses can accomplish knowledge about complete background analysis of the industry which includes
Electrostatic Disinfectant Sprayer Market Size, Share, Demand, Future Growth, Ch …
Global Electrostatic Disinfectant Sprayer Market report puts light on analysis of prime manufacturers, trends, opportunities, marketing strategies analysis, market effect factor analysis and consumer needs by major regions, types, and applications globally. The study offers a comprehensive analysis of the key market dynamics and their latest trends, along with pertinent market segments and sub-segments. The data and information covered in the Electrostatic Disinfectant Sprayer report are obtained from reliable sources
Paint Protection Film Market Size, Share, Trends, Opportunities, Key Drivers and …
Global Paint Protection Film Market study by Data Bridge Market Research provides details about the market dynamics affecting this market, Market scope, Market segmentation and overlays shadow upon the leading market players highlighting the favourable competitive landscape and trends prevailing over the years. The latest market data has been presented in the Paint Protection Film market study on the revenue numbers, product details, and sales of the major firms. In addition

All 5 Releases


More Releases for Chikungunya

Chikungunya Fever Global Clinical Trials Review, H2, 2018: Researchmoz.us
Researchmoz added Most up-to-date research on "Chikungunya Fever Global Clinical Trials Review, H2, 2018" to its huge collection of research reports. An insight on the important factors and trends influencing the market. Latest clinical trial report, Chikungunya Fever Global Clinical Trials Review, H2, 2018" provides an overview of Chikungunya Fever clinical trials scenario. This report provides top line data relating to the clinical trials on Chikungunya Fever. Report includes an overview
Chikungunya Fever Market Segmentation 2018 with Recent Trend by 2023
Chikungunya Fever Market - Highlights Chikungunya fever is a mosquito borne disease. The caU.S.Ative agent is a RNA virus that belongs to the alphavirus genus of the family Togaviridae. The transmission of the disease occurs from human to human by the bites of infected female mosquitoes. Most commonly, the mosquitoes involved are Aedes aegypti and Aedes albopictus. The symptoms of the disease includes muscle pain, headache, nausea, fatigue and rash. There is
Chikungunya Fever Diagnosis, treatments and Global Key players 2017
Chikungunya Fever Summary  Clinical trial report, “Chikungunya Fever Global Clinical Trials Review, H1, 2017" provides an overview of Chikungunya Fever clinical trials scenario. This report provides top line data relating to the clinical trials on Chikungunya Fever. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status,
Chikungunya Fever Market 2018: Key vendors are chikungunya market are Quest Diag …
Chikungunya Fever Market Region Wise surveying Report is added on Marketresearchfuture.com with90 pages. Global Chikungunya Fever market is expected to grow at CAGR 5.86% during forecast period 2018-2023. By Diagnosis (ELISA Based Assays, Serological Tests, Virological Tests), Treatment (Allopathy, Homeopathy), End User (Hospitals And Clinics, Academic Institutes, Research Laboratories) - Global Forecast till 2023 Market Highlights: Chikungunya fever is a mosquito borne disease. The caU.S.Ative agent is a RNA virus that belongs
Chikungunya Fever Business Trends That Will Drive Success In 2023
The study report Global Chikungunya Fever Market covers the market analysis for the regions - North America, Europe, Asia Pacific/ Southeast Asia and RoW and country analysis of China, Japan, and India focusing on top manufacturers in global market and the market share they hold including their contribution to the market growth The Chikungunya Fever Market is expected to grow at CAGR 5.86% during forecast period. Top key players for
Chikungunya Fever Market Global Analysis Research Reports 2023
The Analysis presents the study of Global Chikungunya Fever Market facilitating the regional and country wise analysis covering the strategic analysis of each market player and the market share they hold The Chikungunya Fever Market is expected to grow at CAGR 5.86% during forecast period. Chikungunya is a mosquito borne viral disease caused by the RNA virus belonging to the alphavirus genus of family Togaviridae. Chikungunya fever has been reported in